Welmedix is managed by a committed executive team with extensive experience in brand management, consumer marketing and healthcare. They are advised by a very distinguished Advisory Board of significant accomplishment and management pedigree.


Advisory Board

Doug Rogers

Former President of Wyeth, a $2 Billion consumer healthcare powerhouse with well-known brands including Advil®, Centrum®, and Chapstick®. 


Former President of Standard & Poors, and Executive Vice President of Global Strategy for McGraw-Hill. A distinguished senior business executive with experience leading and advising companies on strategy, operations, sales, marketing and global expansion. 

JIM COlleran

Jim Colleran has over 30 years experience in packaged goods Sales, Marketing and General Management. His extensive experience in skincare was developed at JNJ, where he was Global President of Neutrogena, Global President of Ortho Dermatologics, as well as President of the JNJ Sales and Logistics Company and President of Global Customer Teams.  


Managing Partner of Enlightened Capital Management, a social venture fund, and Principal and Founder of Enlightened Management Corp., a technology advisory group.


Corporate attorney & Partner at Drinker Biddle & Reath LLP, with extensive experience in structuring, negotiating and managing sophisticated securities and corporate transactional matters for both public and private companies. 

Hrishi Dixit

Hrishi Dixit is Technology Advisor for Welmedix and co-founder and Chief Technology Officer of a stealth-mode health-tech startup. Prior to this, he was the Technical Founder and Chief Technology Officer of LearnVest. Hrishi has built and deployed large-scale applications in several domain verticals focused on FinTech and data-driven transactional systems, and has led global engineering teams.

AndY Davis

Former Senior Vice President of Wyeth Consumer Healthcare, Andrew Davis led the launch of Advil® Pain Reliever to become one of the most successful new products ever launched, growing the brand to more than $1 Billion in worldwide sales.